Modulation of growth factor gene expression in vascular cells by oxidative stress

Endothelium: Journal of Endothelial Cell Research

Volumn 11, Issue 2, 2004, Pages 133-139

  Eyries, Melanie ^a   Collins, Tucker ^b   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

AP1; NF kappa ; Oxidative stress; Oxidised LDL; Transcriptional regulation

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE C; PROTEIN KINASE D; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DIABETES MELLITUS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION REGULATION; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS;

EID: 4444348812     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320490482691     Document Type: Review

References (60)

1. Abate C., Patel L., Rauscher F.J. 3rd, and Curran T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249, 1157-1161.
2. Abe J., Takahashi M., Ishida M., Lee J.D., and Berk B.C. (1997) c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. Journal of Biological Chemistry, 272, 20389-20394.
3. Ananyeva N.M., Tjurmin A.V., Berliner J.A., Chisolm G.M., Liau G., Winkles J.A., and Haudenschild C.C. (1997) Oxidized LDL mediates the release of fibroblast growth factor-1. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 445-453.
4. Auge N., Pieraggi M.T., Thiers J.C., Negre-Salvayre A., and Salvayre R. (1995) Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochemical Journal, 309, 1015-1020.
5. Baeuerle P.A., and Baltimore D. (1996) NF-kappa B: Ten years after. Cell, 87, 13-20.
6. Carballo M., Conde M., El Bekay R., Martin-Nieto J., Camacho M.J., Monteseirin J., Conde J., Bedoya F.J., and Sobrino F. (1999) Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. Journal of Biological Chemistry, 274, 17580-17586.
7. Castilla M.A., Caramelo C., Gazapo R.M., Martin O., Gonzalez-Pacheco F.R., Tejedor A., Bragado R., and Arroyo M.V. (2000) Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sciences, 67, 1003-1013.
8. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. (2001) Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Medicine, 7, 425-429.
9. Chang P.Y., Luo S., Jiang T., Lee Y.T., Lu S.C., Henry P.D., and Chen C.H. (2001) Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: Mediator role of platelet-activating factor-like phospholipids. Circulation, 104, 588-593.
10. Chen C.H., Jiang W., Via D.P., Li T.R., Lee Y.T., Henry P.D. (2000) Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation, 101, 171-177.
11. 2 in rat heart endothelial cells. Free Radical in Biology and Medicine, 25, 891-897.
12. Cucina A., Pagliei S., Borrelli V., Corvino V., Stipa F., Cavallaro A., and Sterpetti A.V. (1998) Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells. European Journal of Vascular and Endovascular Surgery, 16, 197-202.
13. De Keulenaer G.W., Alexander R.W., Ushio-Fukai M., Ishizaka N., and Griendling K.K. (1998a) Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochemical Journal, 329, 653-657.
14. De Keulenaer G.W., Chappell D.C., Ishizaka N., Nerem R.M., Alexander R.W., and Griendling K.K. (1998b) Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase. Circulation Research, 82, 1094-1101.
15. Deora A.A., Win T., Vanhaesebroeck B., and Lander H.M. (1998) A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. Journal of Biological Chemistry, 273, 29923-29928.
16. Fabisiak J.P., Evans J.N., and Kelley J. (1989) Increased expression of PDGF-B (c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during chronic hyperoxia. American Journal of Respiratory, Cellular and Molecular Biology, 1, 181-189.
17. Fritz G., and Kaina B. (1999) Phosphorylation of the DNA repair protein APE/REF-1 by CKII affects redox regulation of AP-1. Oncogene, 18, 1033-1040.
18. Goto F., Goto K., Weindel K., and Folkman J. (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Laboratory Investigation, 69, 508-517.
19. Heery J.M., Kozak M., Stafforini D.M., Jones D.A., Zimmerman G.A., McIntyre T.M., and Prescott S.M. (1995) Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. Journal of Clinical Investigation, 96, 2322-2330.
20. Howard A.B., Alexander R.W., Nerem R.M., Griendling K.K., and Taylor W.R. (1997) Cyclic strain induces an oxidative stress in endothelial cells. American Journal of Physiology, 272, C421-C427.
21. Inoue M., Itoh H., Tanaka T., Chun T.H., Doi K., Fukunaga Y., Sawada N., Yamshita J., Masatsugu K., Saito T., Sakaguchi S., Sone M., Yamahara K., Yurugi T., and Nakao K. (2001) Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 560-566.
22. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., Doi K., Ogawa Y., Tamura N., Takaya K., Igaki T., Yamashita J., Chun T.H., Masatsugu K., Becker A.E., and Nakao K. (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation, 98, 2108-2116.
23. Iwasaka C., Tanaka K., Abe M., and Sato Y. (1999) Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. Journal of Cellular Physiology, 169, 522-531.
24. Janssen-Heininger Y.M., Macara I., and Mossman B.T. (1999) Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: Requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. American Journal of Respiratory, Cellular and Molecular Biology, 20, 942-952.
25. Khachigian L.M., Anderson K.R., Halnon N.J., Gimbrone M.A. Jr, Resnick N., and Collins T. (1997) Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arteriosclerosis, Thrombosis and Vascular Biology, 17, 2280-2286.
26. Khachigian L.M., Collins T., and Fries J.W. (1999) N-acetyl cysteine blocks mesangial VCAM-1 and NF-kappa B expression in vivo. American Journal of Pathology, 151, 1225-1229.
27. Kisseleva T., Bhattacharya S., Braunstein J., and Schindler C.W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene, 285, 1-24.
28. Kuzuya M., Ramos M.A., Kanda S., Koike T., Asai T., Maeda K., Shitara K., Shibuya M., and Iguchi A. (2001) VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arteriosclerosis, Thrombosis and Vascular Biology, 21, 765-770.
29. Lander H.M., Ogiste J.S., Teng K.K., and Novogrodsky A. (1995) p21ras as a common signaling target of reactive free radicals and cellular redox stress. Journal of Biological Chemistry, 270, 21195-21198.
30. Lazarous D.F., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A.N., Stiber J.A., Lobo A.D., Hunsberger S., Guetta E., Epstein S.E., and Unger E.F. (1996) Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation, 94, 1074-1082.
31. Malden L.T., Chait A., Raines E.W., and Ross R. (1991) The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. Journal of Biological Chemistry, 266, 13901-13907.
32. Maziere C., Alimardani G., Dantin F., Dubois F., Conte M.A., and Maziere J.C. (1999) Oxidized LDL activates STAT1 and STAT3 transcription factors: Possible involvement of reactive oxygen species. FEBS Letters, 448, 49-52.
33. Maziere C., Conte M.A., and Maziere J.C. (2001) Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radical in Biology and Medicine, 31, 1334-1340.
34. Meng T.C., Fukada T., and Tonks N.K. (2002) Reversible oxidation and inactivation of protein tyrosine phospatases in vivo. Molecular Cell, 9, 387-399.
35. Mitomo K., Nakayama K., Fujimoto K., Sun X., Seki S., and Yamamoto K. (1994) Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene, 145, 197-203.
36. 2 increases expression of pulmonary artery endothelial cell platelet-derived growth factor mRNA. Journal of Applied Physiology, 73, 2255-2262.
37. Nikitovic D., Holmgren A., and Spyrou G. (1998) Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochemical Biophysical Research Communications, 242, 109-112.
38. Nose K., and Ohba M. (1996) Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide. Biochemical Journal, 3, 381-383.
39. Nose K., Shibanuma M., Kikuchi K., Kageyama H., Sakiyama S., and Kuroki T. (1991) Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. European Journal of Biochemistry, 201, 99-106.
40. O'Brien E.R., Garvin M.R., Dev R., Stewart D.K., Hinohara T., Simpson J.B., and Schwartz S.M. (1994) Angiogenesis in human coronary atherosclerotic plaques. American Journal of Pathology, 145, 883-894.
41. Okuno H., Akahori A., Sato H., Xanthoudakis S., Curran T., and Iba H. (1993) Escape from redox regulation enhances the transforming activity of Fos. Oncogene, 8, 695-701.
42. Pinkus R., Weiner L.M., and Daniel V. (1996) Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. Journal of Biological Chemistry, 271, 13422-13429.
43. Pueyo M.E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.F., and Michel J.B. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 645-651.
44. Rao G.N. (1996) Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene, 13, 713-719.
45. Schafer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., and Hocker M. (2003) Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. Journal of Biological Chemistry, 278, 8190-8198.
46. Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M., and Piette J. (2000) Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. Journal of Immunology, 164, 4292-4300.
47. Simon A.R., Rai U., Fanburg B.L., and Cochran B.H. (1998) Activation of the JAK-STAT pathway by reactive oxygen species. American Journal of Physiology, 275, C1640-C1652.
48. Stiko-Rahm A., Hultgardh-Nilsson A., Regnstrom J., Hamsten A., and Nilsson J. (1992) Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arteriosclerosis and Thrombosis, 12, 1099-1109.
49. Stone J.R., and Collins T. (2002) Rapid phosphorylation of heterogeneous nuclear ribonucleoprotein C1/C2 in response to physiologic levels of hydrogen peroxide in human endothelial cells. Journal of Biological Chemistry, 277, 15621-15628.
50. Storz P., and Toker A. (2003) Protein kinase D mediates a stress-induced NF-κB activation and survival pathway. EMBO Journal, 22, 109-120.
51. Takada Y., Mukhopadhyay A., Kundu G.C., Mahabeleshwar G.H., Singh S., and Aggarwal B.B. (2003) Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: Evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. Journal of Biological Chemistry, 278, 24233-24241.
52. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., and Griendling K.K. (1999) Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. Journal of Biological Chemistry, 274, 22699-22704.
53. Van Heek M., Schmitt D., Toren P., Cathcart M.K., DiCorleto P.E. (1998) Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor. Journal of Biological Chemistry, 273, 19405-19410.
54. Virgili F., Ambra R., Muratori F., Natella F., Majewicz J., Minihane A.M., and Rimbach G. (2003) Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells. Antioxidant and Redox Signaling, 5, 237-247.
55. Wung B.S., Cheng J.J., Chao Y.J., Hsieh H.J., and Wang D.L. (1999) Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. Circulation Research, 84, 804-812.
56. Xanthoudakis S., Miao G., Wang F., Pan Y.C., and Curran T. (1992) Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO Journal, 11, 3323-3335.
57. Yang W., and de Bono D.P. (1997) A new role for vascular endothelial growth factor and fibroblast growth factors: Increasing endothelial resistance to oxidative stress. FEBS Letters, 403, 139-142.
58. Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T., and Kuroiwa Y. (1999) Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sciences, 64, 249-258.
59. Zhang H., Schmeisser A., Garlichs C.D., Plotze K., Damme U., Mugge A., and Daniel W.G. (1999) Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: Role of membrane-bound NADH-/NADPH-oxidases. Cardiovascular Research, 44, 215-222.
60. Zhao S.P., and Xu D.Y. (2000) Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells. Clinica Chimica Acta, 296, 121-133.